The progression of IDHmut gliomas from lower grade to grade IV involves multiple CNAs, particularly on chromosome 10q, affecting biologically relevant pathways including: activation of PI3K signaling through loss of PTEN and gain of mTOR, as well as activation of cell cycle signaling through gain of CDK4, CDK6, and cyclinE2. Here, CCNE2 is linked to glioma.